meta-iodo[131i]benzylguanidine sulfate

Poland

Drugs containing this active substance

  • METAIODOBENZYLGUANIDINE 131 I (MIBG-131 I) FOR DIAGNOSIS

    It is a radiopharmaceutical used in cancer diagnostics. It helps to detect, localize, and assess the stage of neuroendocrine tumors (e.g., pheochromocytoma, neuroblastoma, ganglioneuroblastoma, or medullary thyroid carcinoma) and to confirm their nature.

    Form: solution for injection

    Active substance Dosage
    meta-iodo[131i]benzylguanidine sulfate 10-37 MBq/ml

    ATC: V09IX02

    Manufacturer: National Centre for Nuclear Research

  • METAIODOBENZYLGUANIDINE 131 I (MIBG-131 I) FOR THERAPY

    The medicinal product is used in cancer therapy to treat disseminated metastatic lesions of malignant pheochromocytoma, paraganglioma, neuroblastoma, ganglioneuroblastoma, and occasionally medullary thyroid carcinoma.

    Form: solution for injection

    Active substance Dosage
    meta-iodo[131i]benzylguanidine sulfate 370-740 MBq/ml

    ATC: V10XA02

    Manufacturer: National Centre for Nuclear Research